Sionna adopts amended charter/bylaws with IPO completion; eliminates written consent

Sionna Therapeutics, Inc.

Amended charter authorizes 500M common shares and 10M undesignated preferred shares; prior preferred series removed.
Stockholder ability to act by written consent or call special meetings eliminated.
Bylaws updated with advance notice procedures for stockholder proposals and director nominations.
Changes were previously disclosed in the S-1 and became effective upon January 31, 2025 IPO closing.
Governance structure now conforms to typical public company standards.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Sionna Therapeutics, Inc.: Amended and restated bylaws became effective, establishing procedures for stockholder actions at meetings, advance notice procedure for proposals and director nominations, and conforming to amended charter provisions.

Change: bylaw amendment

Exact text from the filing

the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”)

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Sionna Therapeutics, Inc.: Fifth amended and restated certificate of incorporation filed, increasing authorized common stock to 500M shares, eliminating references to prior preferred stock series, authorizing 10M undesignated preferred shares, and eliminating stockholder ability to act by written consent and call special meet (effective 2025-01-31).

Change: charter amendment
Effective: 2025-01-31

Exact text from the filing

the Company filed its fifth amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware on January 31, 2025

View on SEC.gov

188 governance changes filed in the last 30 days. Browse all governance changes →

Sionna Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-023570

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.